The Food and Drug Administration says it will offer ultra-fast review to three psychedelic drugs being studied for hard-to-treat mental health conditions, including major depression. The agency announced the move Friday, following an executive order by President Donald Trump calling for the agency to speed up access to the mind-altering drugs. The move reflects growing popular support for the psychedelics among Trump’s supporters, including combat veterans and followers of the Make America Healthy Again movement. The FDA also greenlighted initial testing of a drug related to ibogaine, a potent psychedelic linked to dangerous heart rhythms.
During the discussion, the group highlighted the importance of expanding mental health resources statewide.
Ford's office has filed three lawsuits against the platforms: TikTok, Snapchat, and three Meta-owned platforms: Instagram, Facebook, and Messenger.
Our Someone 2 Know this week is Emma White, born and raised in Reno. She says during her early teen years - looking at her life from the outside - you would've never known she was battling suicidal depression.
Sponsored Content West Hills Hospital As we approach the colder months we start coming up on Seasonal Affective Disorder. The holidays are supposed to be a time of joy and celebration, but for some people they are anything but. Depression may occur at any
Oakland has become the second U.S. city to decriminalize magic mushrooms.
Voters have made Denver the first U.S. city to decriminalize psilocybin, the psychoactive ingredient in 'magic mushrooms.'
According to Mental Health America’s most recent rankings, Nevada is ranked 51st in mental health services and availability.
Smartphones, which have been linked to teen depression, could help detect the condition in the future.
October 10th is World Mental Health Day - a time to raise awareness about conditions like anxiety and depression that affect hundreds of millions of people worldwide. This year's theme is mental health in the workplace.